(Q24338602)

1

0 references

R B Gartenhaus

2

0 references

D Eichberg

3

0 references

Z Liu

4

0 references

H-B Fang

5

0 references

A P Rapoport

Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells

6

0 references

language of work or name

English

0 references

publication date

7 October 2010

0 references

published in

Oncogene

0 references

volume

29

0 references

issue

40

0 references

page(s)

5464-74

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.275

G2E3 is a nucleo-cytoplasmic shuttling protein with DNA damage responsive localization

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.275

G2E3 is a dual function ubiquitin ligase required for early embryonic development

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.275

PBK/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.275

WAF1, a potential mediator of p53 tumor suppression

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.275

Characterization of PDZ-binding kinase, a mitotic kinase

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.275

Identification of p53 as a sequence-specific DNA-binding protein

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.275

Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.275

Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.275

Characterization of a MAPKK-like protein kinase TOPK

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.275

Protein expression of PDZ-binding kinase is up-regulated in hematologic malignancies and strongly down-regulated during terminal differentiation of HL-60 leukemic cells

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.275

Attenuation of DNA damage checkpoint by PBK, a novel mitotic kinase, involves protein-protein interaction with tumor suppressor p53

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.275

Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.275

T-lymphokine-activated killer cell-originated protein kinase functions as a positive regulator of c-Jun-NH2-kinase 1 signaling and H-Ras-induced cell transformation

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.275

PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cells

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.275

Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.275

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275

A mitotic kinase TOPK enhances Cdk1/cyclin B1-dependent phosphorylation of PRC1 and promotes cytokinesis

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275

PBK/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275

p53 upregulates cFLIP, inhibits transcription of NF-kappaB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275

Regulation of growth-related genes by interleukin-6 in murine myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275

BclxL changes conformation upon binding to wild-type but not mutant p53 DNA binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275

Introduction of wild-type p53 enhances thrombospondin-1 expression in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275

Stable interference of EWS-FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275

Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275

The phosphatase MKP1 is a transcriptional target of p53 involved in cell cycle regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275

Binding of APC to the human homolog of the Drosophila discs large tumor suppressor protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275

p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275

Expression of PDZ-binding kinase (PBK) is regulated by cell cycle-specific transcription factors E2F and CREB/ATF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275

PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275

Molecular interactions of ASPP1 and ASPP2 with the p53 protein family and the apoptotic promoters PUMA and Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275

p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275

Caspase 10 levels are increased following DNA damage in a p53-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275

Comparative biophysical characterization of p53 with the pro-apoptotic BAK and the anti-apoptotic BCL-xL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275

p53 alterations in human cancer: more questions than answers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275

Mutant p53: an oncogenic transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275

WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275

Induction of p21CIP/WAF-1 and G2 arrest by ionizing irradiation impedes caspase-3-mediated apoptosis in human carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275

Lymphokine-activated killer T-cell-originated protein kinase phosphorylation of histone H2AX prevents arsenite-induced apoptosis in RPMI7951 melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275

Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.275